Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Leishmania | Research

Isoenzyme characterization of Leishmania infantum toward checking the antioxidant activity of superoxide dismutase and glutathione peroxidase

Authors: Mostafa Alishvandi¹, Somayeh Bahrami, Sajad Rashidi, Gholamreza Hatam

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Leishmania infantum is the major causative agent of visceral leishmaniasis in Mediterranean regions. Isoenzyme electrophoresis (IE), as a biochemical technique, is applied in the characterization of Leishmania species. The current study attempted to investigate the isoenzyme patterns of logarithmic and stationary promastigotes and axenic amastigotes (amastigote-like) of L. infantum using IE. The antioxidant activity of superoxide dismutase (SOD) and glutathione peroxidase (GPX) was also checked in the aforementioned forms.

Method

After L. infantum cultivation and obtaining logarithmic and stationary promastigotes, axenic amastigotes were achieved by incubation of stationary promastigotes at 37 °C for 48 h. The lysate samples were prepared and examined for six enzymatic systems including glucose-6-phosphate dehydrogenase (G6PD), nucleoside hydrolase 1 (NH1), malate dehydrogenase (MDH), glucose-phosphate isomerase (GPI), malic enzyme (ME), and phosphoglucomutase (PGM). Additionally, the antioxidant activity of SOD and GPX was measured.

Results

GPI, MDH, NH1, and G6PD enzymatic systems represented different patterns in logarithmic and stationary promastigotes and axenic amastigotes of L. infantum. PGM and ME showed similar patterns in the aforementioned forms of parasite. The highest level of SOD activity was determined in the axenic amastigote form and GPX activity was not detected in different forms of L. infantum.

Conclusion

The characterization of leishmanial-isoenzyme patterns and the measurement of antioxidant activity of crucial antioxidant enzymes, including SOD and GPX, might reveal more information in the biology, pathogenicity, and metabolic pathways of Leishmania parasites and consequently drive to designing novel therapeutic strategies in leishmaniasis treatment.
Appendix
Available only for authorised users
Literature
2.
go back to reference Alcover MM, Riera MC, Fisa R. Leishmaniosis in rodents caused by Leishmania infantum: a review of studies in the Mediterranean area. Front Vet Sci. 2021;8:702687.CrossRefPubMedPubMedCentral Alcover MM, Riera MC, Fisa R. Leishmaniosis in rodents caused by Leishmania infantum: a review of studies in the Mediterranean area. Front Vet Sci. 2021;8:702687.CrossRefPubMedPubMedCentral
3.
go back to reference Rashidi S, Kalantar K, Hatam G. Achievement amastigotes of Leishmania infantum and investigation of pathological changes in the tissues of infected golden hamsters. J Parasit Dis. 2018;42:187–95.CrossRefPubMedPubMedCentral Rashidi S, Kalantar K, Hatam G. Achievement amastigotes of Leishmania infantum and investigation of pathological changes in the tissues of infected golden hamsters. J Parasit Dis. 2018;42:187–95.CrossRefPubMedPubMedCentral
6.
go back to reference Veras PST, Bezerra de Menezes JP. Using proteomics to understand how Leishmania parasites survive inside the host and establish infection. Int J Mol Sci. 2016;17(8):1270.CrossRefPubMedPubMedCentral Veras PST, Bezerra de Menezes JP. Using proteomics to understand how Leishmania parasites survive inside the host and establish infection. Int J Mol Sci. 2016;17(8):1270.CrossRefPubMedPubMedCentral
7.
go back to reference Mansouri R, Ali-Hassanzadeh M, Shafiei R, Savardashtaki A, Karimazar M, Anvari E, et al. The use of proteomics for the identification of promising vaccine and diagnostic biomarkers in Plasmodium Falciparum. Parasitology. 2020;147(12):1255–62.CrossRefPubMedPubMedCentral Mansouri R, Ali-Hassanzadeh M, Shafiei R, Savardashtaki A, Karimazar M, Anvari E, et al. The use of proteomics for the identification of promising vaccine and diagnostic biomarkers in Plasmodium Falciparum. Parasitology. 2020;147(12):1255–62.CrossRefPubMedPubMedCentral
8.
go back to reference Ghosh S, Verma A, Kumar V, Pradhan D, Selvapandiyan A, Salotra P, et al. Genomic and transcriptomic analysis for identification of genes and interlinked pathways mediating artemisinin resistance in Leishmania donovani. Genes. 2020;11(11):1362.CrossRefPubMedPubMedCentral Ghosh S, Verma A, Kumar V, Pradhan D, Selvapandiyan A, Salotra P, et al. Genomic and transcriptomic analysis for identification of genes and interlinked pathways mediating artemisinin resistance in Leishmania donovani. Genes. 2020;11(11):1362.CrossRefPubMedPubMedCentral
9.
go back to reference Memarzadeh S, Khanaliha K, Vafafar A, Hatam S, Hatam G. Isoenzyme study of causative agents of leishmaniasis using glutamate dehydrogenase and hexokinase. J Clin Images Med Case Rep. 2022;3(2):1687.CrossRef Memarzadeh S, Khanaliha K, Vafafar A, Hatam S, Hatam G. Isoenzyme study of causative agents of leishmaniasis using glutamate dehydrogenase and hexokinase. J Clin Images Med Case Rep. 2022;3(2):1687.CrossRef
10.
go back to reference Davenport BJ, Martin CG, Beverley SM, Orlicky DJ, Vazquez-Torres A, Morrison TE. SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice. PLoS Negl Trop Dis. 2018;12(10):e0006921.CrossRefPubMedPubMedCentral Davenport BJ, Martin CG, Beverley SM, Orlicky DJ, Vazquez-Torres A, Morrison TE. SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice. PLoS Negl Trop Dis. 2018;12(10):e0006921.CrossRefPubMedPubMedCentral
13.
go back to reference Santi AMM, Murta SMF. Antioxidant defence system as a rational target for Chagas disease and leishmaniasis chemotherapy. Mem Inst Oswaldo Cruz. 2022;117:e210401.CrossRefPubMedPubMedCentral Santi AMM, Murta SMF. Antioxidant defence system as a rational target for Chagas disease and leishmaniasis chemotherapy. Mem Inst Oswaldo Cruz. 2022;117:e210401.CrossRefPubMedPubMedCentral
14.
go back to reference Reverte M, Eren RO, Jha B, Desponds C, Snäkä T, Prevel F, et al. The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolism. PLoS Pathog. 2021;17(3):e1009422.CrossRefPubMedPubMedCentral Reverte M, Eren RO, Jha B, Desponds C, Snäkä T, Prevel F, et al. The antioxidant response favors Leishmania parasites survival, limits inflammation and reprograms the host cell metabolism. PLoS Pathog. 2021;17(3):e1009422.CrossRefPubMedPubMedCentral
15.
go back to reference Louis KS, Siegel AC. Cell viability analysis using trypan blue: manual and automated methods. Mammalian cell Viability: Methods Protocols. 2011:7–12. Louis KS, Siegel AC. Cell viability analysis using trypan blue: manual and automated methods. Mammalian cell Viability: Methods Protocols. 2011:7–12.
16.
go back to reference Gholamreza Hatam SMHH. Isoenzyme studies in characterization of Leishmania isolated in Iran. 1999. Gholamreza Hatam SMHH. Isoenzyme studies in characterization of Leishmania isolated in Iran. 1999.
17.
go back to reference Hatam G, Ardehali S, Riyad M, Bichichi M, Guessous-Idrissi N, Hejazi S. Isoenzyme characterization of Iranian Leishmania isolates from cutaneous leishmaniasis. 2005;29(A1). Hatam G, Ardehali S, Riyad M, Bichichi M, Guessous-Idrissi N, Hejazi S. Isoenzyme characterization of Iranian Leishmania isolates from cutaneous leishmaniasis. 2005;29(A1).
18.
go back to reference Fakhar M, Mikaeili F, Hatam G, Motazedian MH, Habibi P, Fallah E. Application of superior enzymatic systems for characterization of causative agents of visceral leishmaniasis (kala-azar) in Iran using isoenzyme electrophoresis. J Maz Univ Med Sci. 2009;19(70):41–8. Fakhar M, Mikaeili F, Hatam G, Motazedian MH, Habibi P, Fallah E. Application of superior enzymatic systems for characterization of causative agents of visceral leishmaniasis (kala-azar) in Iran using isoenzyme electrophoresis. J Maz Univ Med Sci. 2009;19(70):41–8.
19.
go back to reference Calvopina M, Armijos RX, Marco JD, Uezato H, Kato H, Gomez EA, et al. Leishmania Isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation. BMC Infect Dis. 2006;6:139.CrossRefPubMedPubMedCentral Calvopina M, Armijos RX, Marco JD, Uezato H, Kato H, Gomez EA, et al. Leishmania Isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation. BMC Infect Dis. 2006;6:139.CrossRefPubMedPubMedCentral
20.
go back to reference Hatam GR, Bahrami S, Razavi SM, Oryan A. Isoenzyme and ultrastructural characterization of Leishmania Tropica axenic amastigotes and promastigotes. Parasitol Res. 2013;112:643–8.CrossRefPubMed Hatam GR, Bahrami S, Razavi SM, Oryan A. Isoenzyme and ultrastructural characterization of Leishmania Tropica axenic amastigotes and promastigotes. Parasitol Res. 2013;112:643–8.CrossRefPubMed
21.
go back to reference Roma EH, Macedo JP, Goes GR, Gonçalves JL, Castro Wd, Cisalpino D, et al. Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection. Parasit Vectors. 2016;9:193.CrossRefPubMedPubMedCentral Roma EH, Macedo JP, Goes GR, Gonçalves JL, Castro Wd, Cisalpino D, et al. Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection. Parasit Vectors. 2016;9:193.CrossRefPubMedPubMedCentral
22.
go back to reference Carneiro PP, Conceição J, Macedo M, Magalhães V, Carvalho EM, Bacellar O. The role of nitric oxide and reactive oxygen species in the killing of Leishmania braziliensis by monocytes from patients with cutaneous leishmaniasis. PLoS ONE. 2016;11(2):e0148084.CrossRefPubMedPubMedCentral Carneiro PP, Conceição J, Macedo M, Magalhães V, Carvalho EM, Bacellar O. The role of nitric oxide and reactive oxygen species in the killing of Leishmania braziliensis by monocytes from patients with cutaneous leishmaniasis. PLoS ONE. 2016;11(2):e0148084.CrossRefPubMedPubMedCentral
24.
go back to reference El-On J, Bradley D, Freeman J. Leishmania donovani: action of excreted factor on hydrolytic enzyme activity of macrophages from mice with genetically different resistance to infection. Exp Parasitol. 1980;49(2):167–74.CrossRefPubMed El-On J, Bradley D, Freeman J. Leishmania donovani: action of excreted factor on hydrolytic enzyme activity of macrophages from mice with genetically different resistance to infection. Exp Parasitol. 1980;49(2):167–74.CrossRefPubMed
25.
go back to reference Bichiou H, Rabhi S, Ben Hamda C, Bouabid C, Belghith M, Piquemal D, et al. Leishmania parasites differently regulate antioxidant genes in macrophages derived from resistant and susceptible mice. Front Cell Infect Microbiol. 2021;11:748738.CrossRefPubMedPubMedCentral Bichiou H, Rabhi S, Ben Hamda C, Bouabid C, Belghith M, Piquemal D, et al. Leishmania parasites differently regulate antioxidant genes in macrophages derived from resistant and susceptible mice. Front Cell Infect Microbiol. 2021;11:748738.CrossRefPubMedPubMedCentral
26.
go back to reference Ighodaro O, Akinloye O. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria Med J. 2018;54(4):287–93.CrossRef Ighodaro O, Akinloye O. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria Med J. 2018;54(4):287–93.CrossRef
27.
go back to reference Benhar M. Roles of mammalian glutathione peroxidase and thioredoxin reductase enzymes in the cellular response to nitrosative stress. Free Radic Biol Med. 2018;127:160–4.CrossRefPubMed Benhar M. Roles of mammalian glutathione peroxidase and thioredoxin reductase enzymes in the cellular response to nitrosative stress. Free Radic Biol Med. 2018;127:160–4.CrossRefPubMed
28.
go back to reference Amiri-Dashatan N, Koushki M, Rezaei-Tavirani M, Ahmadi N. Stage-specific Differential Gene expression of glutathione peroxidase in Leishmania major and Leishmania Tropica. Rep Biochem Mol Biol. 2020;9(3):324.CrossRefPubMedPubMedCentral Amiri-Dashatan N, Koushki M, Rezaei-Tavirani M, Ahmadi N. Stage-specific Differential Gene expression of glutathione peroxidase in Leishmania major and Leishmania Tropica. Rep Biochem Mol Biol. 2020;9(3):324.CrossRefPubMedPubMedCentral
Metadata
Title
Isoenzyme characterization of Leishmania infantum toward checking the antioxidant activity of superoxide dismutase and glutathione peroxidase
Authors
Mostafa Alishvandi¹
Somayeh Bahrami
Sajad Rashidi
Gholamreza Hatam
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09069-7

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.